DeCarley Trading - Futures, Options, Integrity

DeCarley Trading strives to offer the highest quality futures and options brokerage services at competitive rates. Whether you prefer trading online via a state-of-the-art trading platform, or with an experienced commodity broker, we are confident DeCarley is capable of exceeding your expectations.

Meet Our Brokers

Meet Carley Garner

CarleyDeskShot 2020Senior Commodity Market Strategist and Broker, STOCKS & COMMODITIES Magazine Columnist, TheStreet.com, Mad Money Contributor, and Author

Carley Garner is an experienced futures and options broker with DeCarley Trading, a division of Zaner Group, in Las Vegas, Nevada. Her commodity market analysis is often referenced on Jim Cramer’s Mad Money on CNBC and she is a regular contributor to TheStreet.com and its Real Money Pro service. Garner is also a regular on the speaking circuit and can be found at TradersEXPOs and MoneyShows throughout the country.


Garner is also the author of Higher Probability Commodity Trading; A Trader's First Book on Commodities (three editions); Currency Trading in the Forex and Futures Markets; and Commodity Options. Her e-newsletters, The DeCarley Perspective, and The Financial Futures Report have garnered aCarley Garner and Jim Cramer on the Mad Money set loyal following; she is also proactive in providing free trading education at www.DeCarleyTrading.com.


Carley is a magna cum laude graduate of the University of Nevada Las Vegas, from which she earned dual bachelor’s degrees in finance and accounting. Carley jumped into the options and futures industry with both feet in early 2004 and has become one of the most recognized names in the business.


Carley authors a monthly column in STOCKS & COMMODITIES magazine and has been featured in the likes of Futures, Active Trader, Option Trader magazines, and many more. She has been quoted by Investor’s Business Daily and The Wall Street Journal and has also been known to participate in radio interviews.

 

 

Share

 
 

Follow us on Instagram

 

Newsletter Trial